Kal Tsanov (@ktsanov) / X

Kal Tsanov

1,065 posts

Kal Tsanov

@ktsanov

Assistant Professor @UChicago | cancer • epi/genetics • metastasis • stem cells

New York, USA

Joined May 2009

Pinned
Kal Tsanov
@ktsanov
Aug 23, 2024
18 years ago, I came to the US to pursue my dream of becoming a scientist. Last week marked a major milestone in this journey, as I accepted an Assistant Professor position at @UChicago, where I am thrilled to start my own research group in January 2025! (1/5)
154K
Kal Tsanov
@ktsanov
Dec 23, 2021
Favorite @sloan_kettering holiday tradition. Walking through the incredible 'Holiday Hallway' created by our phenomenal Facilities team. Thank you & happy holidays to everyone!
00:00
Kal Tsanov
@ktsanov
Aug 30, 2022
My 1st-ever @NIH @theNCI NOA! Deeply grateful to all my mentors & colleagues, and for this nation’s continued support of my education & research. Excited to continue my efforts to better understand & target #PancreaticCancer #Metastasis! (1/2)
Lowe Lab
@LoweLabMSKCC
Aug 30, 2022
Congratulations to postdoc @KTsanov on receiving the @NIH K99/R00 Pathway to Independence Award!! 👏🎉🚀
Kal Tsanov
@ktsanov
Mar 20, 2024
Excited to share our latest preprint! Here, we asked: Does a tumor’s dependence on driver mutations change after it spreads to other organs? This led us to uncover a critical interplay b/w tumor #Genetics, #Epigenetics and #AnatomicLocation... 🧵 1/n
biorxiv.org
Metastatic site influences driver gene function in pancreatic cancer
Driver gene mutations can increase the metastatic potential of the primary tumor[1][1]–[3][2], but their role in sustaining tumor growth at metastatic sites is poorly understood. A paradigm of such...
17K
Kal Tsanov
@ktsanov
May 16, 2024
Truly honored by this recognition, which is really a reflection of the phenomenal mentorship, environment & colleagues, incl. key collaborators @LoweLabMSKCC @MSKCancerCenter. Thank you! 🙏
Lowe Lab
@LoweLabMSKCC
May 16, 2024
Congratulations to postdoc @KTsanov on receiving the 2024 MSK Postdoctoral Research Award, in recognition of outstanding accomplishments & promise! 👏🥳🎉@MSKCancerCenter @MSKEducation #Convocation2024
9.9K
Kal Tsanov
@ktsanov
Jan 4, 2024
The final version of our manuscript that develops the #EPOGEMM platform of mouse models to study #MetastaticGastricCancer. 6 diff genotypes + 4 diff genetic backgrounds = new insights into the interplay b/w metastatic site, tumor genotype & immune surveillance. 🧬⚡🐭 (1/4)
Lowe Lab
@LoweLabMSKCC
Jan 4, 2024
First publication of 2024! Now out in @NatureCancer, the final (and substantially expanded) version of our work that develops a new suite of mouse models to study #MetastaticGastricCancer of customizable #Genotypes and #HostBackgrounds: nature.com/articles/s4301….
11K
Kal Tsanov
@ktsanov
Aug 5, 2023
First time at the @SalkInstitute Cancer Meeting & had a blast. Thanks to the organizers for a great conference -- see you next time! 🙂 #MechModels2023
5.5K
Kal Tsanov
@ktsanov
Jun 16, 2022
My 1st preprint! Great collaboration with the amazing @JosefLeibold @TeamJJTueb (EPO-GEMM pioneer) & @Corina_Amor_MD @Amor_lab. #GastricCancer is on the rise, understudied & needs flexible #MouseModels. More to come but excited to share our work so far. 🧬⚡️🐭 #EPOGEMMs #teamwork
Lowe Lab
@LoweLabMSKCC
Jun 15, 2022
Pre-print Alert! Today we report the development of rapid & flexible platform for #GastricCancer mouse modeling and use it to produce a suite of models w/ different #Genotypes & #HostBackgrounds, uncovering genotype-specific features of #MetastaticDisease. biorxiv.org/content/10.110…
Kal Tsanov
@ktsanov
Aug 23, 2022
New preprint, super fun collaboration with the amazing Pancho 'MACHETE' @BarrigaFM! We present a flexible method to study large genomic deletions & use it to uncover how the pervasive 9p21 dels promote tumor immune evasion & metastasis. 🧬🔪🧬#MACHETE #Cancer #Deletions #Teamwork
Lowe Lab
@LoweLabMSKCC
Aug 23, 2022
New Preprint! Led by #DynamicDuo @BarrigaFM & @KTsanov, this study set out to understand how somatic copy number alterations (CNAs) promote cancer. CNAs are prevalent across cancer types & correlate w/ clinical outcomes but remain difficult to study. 1/n biorxiv.org/content/10.110…
Kal Tsanov
@ktsanov
Nov 15, 2022
Had a blast celebrating my inspiring friend @DirenaAC's Blavatnik Award. Big congratulations to her & the other 2021-22 @BlavatnikAwards honorees! 👏🥳🚀
Kal Tsanov
@ktsanov
Sep 23, 2023
Another fantastic CSHL Cancer Meeting for the books! Had a blast presenting our work, hearing about all the exciting advances in the field, and hanging out with old & new friends -- CSHL style! See you next time. @cshlmeetings #cshlcancer
2.2K
Kal Tsanov
@ktsanov
Nov 7, 2022
And a great editorial by @IanDemsky @MSKCancerCenter! #MACHETE #Cancer #Deletions #Teamwork
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Nov 7, 2022
Watch out @officialDannyT, there’s a new MACHETE in town — a powerful technique developed at MSK's Sloan Kettering Institute to study frequent, large-scale genetic deletions in #cancer called copy number alterations. mskcc.org/news/new-mache…
Kal Tsanov
@ktsanov
Sep 18, 2023
Won some $$$! 🙂 Super fun to be part of this year's #MSKPostdocSlam. Congrats @AnnelisaCornel @magdalinipan & all fellow finalists, who did a great job! And BIG thanks to the amazing @MSKEducation team!
MSK ScienceEducation
@MSKEducation
Sep 18, 2023
Replying to @MSKEducation
1st place winner @AnnelisaCornel! 2nd place @magdalinipan! 3rd place @ktsanov! And people’s choice winner @magdalinipan!
3.2K
Kal Tsanov
@ktsanov
May 8, 2023
The Metastasis @KeystoneSymp has begun! Thrilled to learn from & connect with the community, and grateful for the opportunity to present our work this afternoon. #KSMetastasis23 #KSTumorResist23
11K